| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10903934 | Experimental Cell Research | 2015 | 8 Pages |
Abstract
Sorafenib together with inhibitors of the β-catenin pathway might be an effective tool in the treatment of pediatric HCC.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Carmen Nagel, Sorin Armeanu-Ebinger, Alexander Dewerth, Steven W. Warmann, Jörg Fuchs,